Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Arinna Lifesciences

Tracked across 3 events · 29 articles · First seen Apr 14, 2026 · Last active Aug 19, 2026

Sentiment
43
Attention
4
Events
3
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Business
Impact: Arinna Lifesciences was acquired by Rubicon Research for approximately INR 175.92 crore for an 85% stake. Its founder, Vivek Seth, will retain a 15% stake and continue as Managing Director, providing continuity and leveraging its existing network for Rubicon Research.
Apr 14, 2026 · 8 articles
2 30
Business
Impact: Arinna Lifesciences, a subsidiary of Parijat, will secure exclusive rights to use HELM branding in India, supporting the launch of new product lines.
Aug 17, 2026 · 6 articles
4 40
Business
Impact: Arinna Lifesciences has a collaboration with Molbio for cancer screening, but is not directly involved in the IPO.
Aug 05, 2026 · 15 articles
India ↔ Arinna Lifesciences
India ↔ Arinna Lifesciences
ERGEN INTELLIGENCE
Track Arinna Lifesciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.